ISRCTN85462326进行中（未招募）未知
A randomised CONtrolled trial of Tailored Acceptance and Commitment Therapy for older people with treatment-resistant generalised anxiety disorder (CONTACT-GAD)
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 296
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •For older people with a treatment-resistant generalised anxiety disorder (TR-GAD):
- •1. People aged 60 years and over
- •2. Diagnosis of GAD using the Mini-International Neuropsychiatric Interview
- •3. GAD that is ‘treatment resistant’, defined as GAD that has failed to respond adequately to pharmacotherapy and/or psychotherapy treatment, as described in step 3 of the UK's stepped care model for GAD. GAD that has failed to respond adequately will be defined as continued symptoms of GAD that are still causing difficulties. Those who have been offered pharmacotherapy and/or psychotherapy treatment and did not want to start it or continue it and are still symptomatic will also be included in this definition. When determining whether GAD has failed to respond adequately to treatment, if a person has remitted and then relapsed in relation to GAD then any treatment received prior to remission will not be considered when deciding whether they meet the criteria for TR-GAD
- •4. Living in the community (i.e. those living in domestic residences or assisted living facilities, but not care homes)
- •The Mini-International Neuropsychiatric Interview has been modified for the purpose of this trial, with questions surrounding suicidality removed. The expression of suicidal ideation with active suicidal behaviours/plans and active intent is instead assessed via the Geriatric Suicide Ideation Scale, as detailed in the principal exclusion criteria.
- •For study therapists completing the qualitative satisfaction questionnaire:
- •1. Aged 18 years and over
- •2. Therapists involved in intervention delivery within the CONTACT-GAD trial
排除标准
- •Current participant exclusion criteria as of 05/05/2023:
- •For older people with TR-GAD:
- •1. Judged to lack the capacity to provide fully informed written consent to participate in the trial
- •2. A diagnosis of dementia or intellectual disability using standard diagnostic guidelines, or clinically judged to have moderate or severe cognitive impairment (e.g. due to probable dementia, traumatic brain injury, stroke, etc)
- •3. A diagnosis of an imminently life-limiting illness where they would not be expected to survive for the duration of the study
- •4. Expressing suicidal ideation with active suicidal behaviours/plans and active intent, as assessed using the Columbia-Suicide Severity Rating Scale Screener, for whom an inpatient admission would be more appropriate
- •5. Currently receiving a course of formal psychological therapy delivered by a formally trained psychologist or psychotherapist (e.g. cognitive behavioural therapy, psychodynamic psychotherapy, systemic therapy, counselling, etc), or those who are unwilling to refrain from engaging in such formal psychological therapy should they be randomly allocated to the ACT arm
- •6. Self-report having received ACT in the FACTOID feasibility study
- •7. Having already been randomised in the CONTACT-GAD trial or living with another person who has already been randomised in the CONTACT-GAD trial
- •8. Taking part in clinical trials of other interventions for GAD
- •Previous participant exclusion criteria:
- •For older people with TR-GAD:
- •1. Judged to lack the capacity to provide fully informed written consent to participate in the trial
- •2. A diagnosis of dementia or intellectual disability using standard diagnostic guidelines, or clinically judged to have moderate or severe cognitive impairment (e.g. due to probable dementia, traumatic brain injury, stroke, etc)
- •3. A diagnosis of an imminently life-limiting illness where they would not be expected to survive for the duration of the study
- •4. Expressing suicidal ideation with active suicidal behaviours/plans and active intent, as assessed using the Geriatric Suicide Ideation Scale, for whom an inpatient admission would be more appropriate
- •5. Currently receiving a course of formal psychological therapy delivered by a formally trained psychologist or psychotherapist (e.g. cognitive behavioural therapy, psychodynamic psychotherapy, systemic therapy, counselling, etc), or those who are unwilling to refrain from engaging in such formal psychological therapy should they be randomly allocated to the ACT arm
- •6. Self-report having received ACT in the FACTOID feasibility study
- •7. Having already been randomised in the CONTACT-GAD trial or living with another person who has already been randomised in the CONTACT-GAD trial
- •8. Taking part in clinical trials of other interventions for GAD
研究者
相似试验
已完成
不适用
A randomised controlled trial to assess the acceptability of a switch from Suboxone Registered Trademark (R) sublingual tablets to Suboxone(R) sublingual film.Opioid dependencyOpioid substitution therapy for opioid dependenceMental Health - AddictionACTRN12611000545965Associate Professor Nicholas Lintzeris100
已完成
不适用
Effectiveness Of Acceptance and Commitment Therapy on male smokersCondition 1: nicotine dependence. Condition 2: depression. Condition 3: anxiety.Mental and behavioural disorders due to use of tobaccoTwo or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities.Anxiety NOSIRCT2017011932057N1Vice chancellor for research of Kashan University of Medical Sciences and Health Services70
已完成
不适用
Acceptability and effectiveness of multi-media delivery of an exercise programme among postpartum women with lumbo pelvic pain in TaiwaISRCTN51146251niversity of Bedfordshire240
已完成
不适用
A randomised controlled trial of Te Whanau Pou Toru: Maori Adaptation of Primary Care Triple P Discussion Groups for Maori parents of young children with behavioural difficulties.Child behaviourParenting practicesACTRN12617000210370Dr Louise Keown50
招募中
不适用
Efficacy of acceptance-mindfulness therapy in children with anxiety: a controlled trialMental Health - AnxietyAnxiety DisorderACTRN12611001280998Children's Hospital Westmead, Department of Psychological Medicine150